glp -1 drugs How GLP-1 medications are transforming diabetes and weight loss treatment GLP-1 for Drug Addiction |

Articles on GLP-1RA or SGLT2-I used in combination with therapies other than MET were excluded

December 2025: Ascletis Pharma announced that ASC30, an oral small-molecule GLP-1 receptor agonist, demonstrated 7.7% placebo-adjusted weight loss in a 13-week U.S

Semaglutide (Wegovy) Highlight: This is one of the most well-known GLP-1s it has the same main ingredient as the brand name Ozempic which is only approved for use in Type 2 Diabetes

Dipeptidyl peptidase IV inhibition attenuates blood pressure rising in young spontaneously hypertensive rats

The medication encourages your body to dump sodium reserves, leaving less ionic material to regulate your water levels

Transdermal chromium delivery is not well-established in peer-reviewed literature